pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
OR-449
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Orphagen Pharmaceuticals Inc
0 catalysts
Preclinical
OR-812
Male Contraception
Orphagen Pharmaceuticals Inc
0 catalysts
Preclinical
ORG-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Orgenesis Inc
0 catalysts
Phase 2
ORKA-001
Plaque Psoriasis (Psoriasis Vulgaris)
← prev
page 118 of 231
next →
131
Pain89
Neurology1
$ORKAOruka Therapeutics, Inc.
0 catalysts
Phase 2
ORTHO-R
Unspecified Musculoskeletal Disorders
ChitogenX Inc
0 catalysts
Phase 2
ORX-142
Sleep Disorders
$CNTACentessa Pharmaceuticals plc
0 catalysts
Preclinical
OS-151
Tuberculosis
OncoSTING LLC
0 catalysts
Phase 3
OSE-2101
Tedopi
Non-Small Cell Lung Cancer
OSE Immunotherapeutics SA
0 catalysts
Preclinical
OT-004
Leber Congenital Amaurosis (LCA)
Odylia Therapeutics Inc
0 catalysts
Phase 2
OTL-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Kyowa Kirin Co Ltd
0 catalysts
Phase 1
OTOV-101
Deafness
Suzhou Otovia Therapeutics Co Ltd
0 catalysts
Phase 1
OTS-167
Metastatic Breast Cancer
OncoTherapy Science Inc
0 catalysts
Phase 1
OV-329
Seizures
$OVIDOvid Therapeutics Inc.
0 catalysts
Preclinical
OX-390
Acute Opioid Overdosage
Orexo AB
0 catalysts
Phase 2
OXI-4503
Refractory Acute Myeloid Leukemia
$OTLCOncotelic Therapeutics, Inc.
0 catalysts
OXYGEN
OXYGEN (OXYGEN)
AIR LIQUID INDUSTRIAL US LP
0 catalysts
OZILTUS
OZILTUS (DENOSUMAB-MOBZ)
AMNEAL PHARMS LLC
0 catalysts
Preclinical
Obesity
Obesity
Metallomix Inc
0 catalysts
Preclinical
Oligonucleotide for Charcot-Marie-Tooth Disease Type I A
Charcot-Marie-Tooth Disease Type I A
MaasiRNA
0 catalysts
Phase 3
OncoVAX
Colon Cancer
Vaccinogen Inc
0 catalysts
Preclinical
Oncolipin-IT
Colorectal Cancer
XEME BioPharma Inc
0 catalysts
Preclinical
Oncoplex
Glioblastoma Multiforme (GBM)
$PYPDPolyPid Ltd.
0 catalysts
Phase 1
Oncoquest
Chronic Lymphocytic Leukemia (CLL)
XEME BioPharma Inc
0 catalysts
Marketed
Oncotice
Tice BCG
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
0 catalysts
Marketed
Opzelura
Opzelura (ruxolitinib phosphate)
Hidradenitis Suppurativa
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
$INCYINCYTE CORP
0 catalysts
Marketed
Orabloc
Orabloc ((articaine hydrochloride + epinephrine bitartrate))
Local Anesthetic Effect
Pierrel SpA
0 catalysts
Phase 2
Organ Dysfunction/Mortality
Unspecified
BioAegis Therapeutics Inc
0 catalysts
Phase 2
OriCAR-017
Refractory Multiple Myeloma
Oricell Therapeutics (Shanghai) Co Ltd
0 catalysts